FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Bayer HealthCare Pharmaceuticals Leukine sargramostim 5 x 500 mcg/mL vial Recall

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Ba…

Bayer HealthCare Pharmaceuticals Inc. · Lynnwood, WA

Risk level
Class III
Reported by FDA
Feb 13, 2013
Recall ID
D-156-2013
Check your lot numberHow we source this data

Summary

Bayer HealthCare Pharmaceuticals recalled Leukine sargramostim 5 x 500 mcg/mL vial starting May 31, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-156-2013 on Feb 13, 2013. Reason: Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point. Status: Terminated.

Why it was recalled

Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.

Product description

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Lot numbers, UPCs & expiration codes

B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-156-2013
Classification
Class III
Status
Terminated
Recall initiated
May 31, 2012
FDA report date
Feb 13, 2013
Quantity
138,505 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Bayer HealthCare Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-156-2013, exactly as published.

Show all FDA fields
City
Lynnwood
State
WA
Status
Terminated
Country
United States
Event ID
62908
Address
2625 162nd St SW
Code information
B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12
Postal code
98087
Report date
Feb 13, 2013
Product type
Drugs
Recall number
D-156-2013
Classification
Class III
Recalling firm
Bayer HealthCare Pharmaceuticals Inc.
Product quantity
138,505 vials
Termination date
May 10, 2013
Reason for recall
Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2
Distribution pattern
Nationwide
Recall initiation date
May 31, 2012
Initial firm notification
Letter
Center classification date
Feb 7, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-156-2013, published Feb 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls